Cubist Systematic Strategies, LLC Vir Biotechnology, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 174,740 shares of VIR stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

174,740

Previous 188,624 7.36%

Holding current value

$1.8 Million

Previous $1.68 Million 22.05%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.26 - $10.7 $100,797 - $148,558	-13,884 Reduced 7.36%	174,740 $1.31 Million
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $1.42 Million - $2.35 Million	185,723 Added 6402.03%	188,624 $1.68 Million
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $1.81 Million - $2.5 Million	-210,288 Reduced 98.64%	2,901 $29,000
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $591,637 - $784,530	76,242 Added 55.67%	213,189 $2.14 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $1.25 Million - $3.37 Million	136,947 New	136,947 $1.28 Million
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $147,850 - $204,905	-6,642 Reduced 34.14%	12,815 $298,000
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $1.72 Million - $2.43 Million	-86,050 Reduced 81.56%	19,457 $492,000
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $1.1 Million - $1.88 Million	-60,434 Reduced 36.42%	105,507 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $103,757 - $145,194	5,438 Added 3.39%	165,941 $4.23 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $1.47 Million - $2.78 Million	69,604 Added 76.57%	160,503 $4.13 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $2.63 Million - $4.59 Million	85,035 Added 1450.12%	90,899 $3.81 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $901,885 - $1.41 Million	-25,842 Reduced 81.51%	5,864 $255,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $604,693 - $795,855	15,605 Added 96.92%	31,706 $1.5 Million
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $424,100 - $1.34 Million	16,101 New	16,101 $825,000

Others Institutions Holding VIR

# of Institutions

214

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.36B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Vir Biotechnology, Inc. Transaction History